

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle adaptation (GO:0043501) | 8.53336330 |
| 2 | actin filament-based movement (GO:0030048) | 8.46099831 |
| 3 | skeletal muscle fiber development (GO:0048741) | 7.49076989 |
| 4 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.39123087 |
| 5 | cytidine catabolic process (GO:0006216) | 7.25465638 |
| 6 | cytidine deamination (GO:0009972) | 7.25465638 |
| 7 | cytidine metabolic process (GO:0046087) | 7.25465638 |
| 8 | myotube cell development (GO:0014904) | 6.49349142 |
| 9 | striated muscle contraction (GO:0006941) | 6.35605986 |
| 10 | sarcomere organization (GO:0045214) | 6.22764278 |
| 11 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.12356157 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.12131340 |
| 13 | regulation of cell communication by electrical coupling (GO:0010649) | 5.99117899 |
| 14 | myofibril assembly (GO:0030239) | 5.93666752 |
| 15 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.71487097 |
| 16 | skeletal muscle tissue regeneration (GO:0043403) | 5.61329470 |
| 17 | muscle contraction (GO:0006936) | 5.53189428 |
| 18 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.27113172 |
| 19 | response to muscle activity (GO:0014850) | 5.20818116 |
| 20 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.15222968 |
| 21 | creatine metabolic process (GO:0006600) | 5.13066933 |
| 22 | glycogen catabolic process (GO:0005980) | 5.12836928 |
| 23 | muscle system process (GO:0003012) | 4.93405792 |
| 24 | striated muscle atrophy (GO:0014891) | 4.85657802 |
| 25 | carnitine shuttle (GO:0006853) | 4.83532003 |
| 26 | striated muscle adaptation (GO:0014888) | 4.83049300 |
| 27 | glucan catabolic process (GO:0009251) | 4.77990397 |
| 28 | purine nucleotide salvage (GO:0032261) | 4.74246128 |
| 29 | response to inactivity (GO:0014854) | 4.66879178 |
| 30 | IMP metabolic process (GO:0046040) | 4.66516276 |
| 31 | muscle fiber development (GO:0048747) | 4.62010059 |
| 32 | glucan biosynthetic process (GO:0009250) | 4.59086840 |
| 33 | glycogen biosynthetic process (GO:0005978) | 4.59086840 |
| 34 | muscle atrophy (GO:0014889) | 4.57929163 |
| 35 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.56294264 |
| 36 | cellular polysaccharide catabolic process (GO:0044247) | 4.52209094 |
| 37 | regulation of relaxation of muscle (GO:1901077) | 4.51006580 |
| 38 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.46237156 |
| 39 | actomyosin structure organization (GO:0031032) | 4.43182105 |
| 40 | muscle adaptation (GO:0043500) | 4.23618434 |
| 41 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.22331492 |
| 42 | polysaccharide catabolic process (GO:0000272) | 4.21252712 |
| 43 | skeletal muscle tissue development (GO:0007519) | 4.18902093 |
| 44 | fatty acid transmembrane transport (GO:1902001) | 4.10778968 |
| 45 | muscle organ development (GO:0007517) | 3.93804091 |
| 46 | muscle structure development (GO:0061061) | 3.90967577 |
| 47 | IMP biosynthetic process (GO:0006188) | 3.86070182 |
| 48 | response to activity (GO:0014823) | 3.83198542 |
| 49 | regulation of myoblast differentiation (GO:0045661) | 3.82884615 |
| 50 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.80441756 |
| 51 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.60240265 |
| 52 | glycogen metabolic process (GO:0005977) | 3.55108209 |
| 53 | striated muscle cell development (GO:0055002) | 3.53948689 |
| 54 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.47837463 |
| 55 | glucan metabolic process (GO:0044042) | 3.47346382 |
| 56 | cellular glucan metabolic process (GO:0006073) | 3.47346382 |
| 57 | cardiac myofibril assembly (GO:0055003) | 3.43435241 |
| 58 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.40538130 |
| 59 | cardiac muscle contraction (GO:0060048) | 3.39465646 |
| 60 | positive regulation of myoblast differentiation (GO:0045663) | 3.38818677 |
| 61 | neuronal action potential propagation (GO:0019227) | 3.33392091 |
| 62 | regulation of coenzyme metabolic process (GO:0051196) | 3.33096828 |
| 63 | regulation of cofactor metabolic process (GO:0051193) | 3.33096828 |
| 64 | heart contraction (GO:0060047) | 3.33055723 |
| 65 | heart process (GO:0003015) | 3.33055723 |
| 66 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.32359974 |
| 67 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.32359974 |
| 68 | muscle cell cellular homeostasis (GO:0046716) | 3.28588816 |
| 69 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.27273911 |
| 70 | carnitine transmembrane transport (GO:1902603) | 3.26533634 |
| 71 | negative regulation of muscle hypertrophy (GO:0014741) | 3.25537293 |
| 72 | myotube differentiation (GO:0014902) | 3.20457266 |
| 73 | neuromuscular synaptic transmission (GO:0007274) | 3.19967539 |
| 74 | negative regulation of protein localization to cell surface (GO:2000009) | 3.14781427 |
| 75 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.12916265 |
| 76 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.11961992 |
| 77 | positive regulation of cation channel activity (GO:2001259) | 3.09188807 |
| 78 | positive regulation of myotube differentiation (GO:0010831) | 3.09023474 |
| 79 | regulation of sarcomere organization (GO:0060297) | 3.07559414 |
| 80 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.07250073 |
| 81 | negative regulation of muscle contraction (GO:0045932) | 3.06177779 |
| 82 | regulation of skeletal muscle fiber development (GO:0048742) | 3.06033342 |
| 83 | cardiac muscle cell development (GO:0055013) | 3.01690346 |
| 84 | regulation of striated muscle contraction (GO:0006942) | 2.97907301 |
| 85 | striated muscle hypertrophy (GO:0014897) | 2.95602237 |
| 86 | muscle cell development (GO:0055001) | 2.94293627 |
| 87 | tricarboxylic acid cycle (GO:0006099) | 2.89905754 |
| 88 | carnitine transport (GO:0015879) | 2.88894492 |
| 89 | amino-acid betaine transport (GO:0015838) | 2.88894492 |
| 90 | striated muscle tissue development (GO:0014706) | 2.87357841 |
| 91 | DNA demethylation (GO:0080111) | 2.84796768 |
| 92 | muscle hypertrophy (GO:0014896) | 2.84440041 |
| 93 | cytoplasmic microtubule organization (GO:0031122) | 2.82759261 |
| 94 | actin-myosin filament sliding (GO:0033275) | 13.5530961 |
| 95 | muscle filament sliding (GO:0030049) | 13.5530961 |
| 96 | skeletal muscle contraction (GO:0003009) | 11.2664617 |
| 97 | actin-mediated cell contraction (GO:0070252) | 11.2333219 |
| 98 | regulation of skeletal muscle contraction (GO:0014819) | 11.2085069 |
| 99 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.3106395 |
| 100 | plasma membrane repair (GO:0001778) | 10.2011502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.10185844 |
| 2 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.73762767 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.62950278 |
| 4 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.52938985 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.52938985 |
| 6 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.41070172 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.29319732 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.14070212 |
| 9 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.13458154 |
| 10 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.07892356 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.07162210 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.06300296 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 10.2872297 |
| 14 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.94362312 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85929421 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.75987176 |
| 17 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.68667347 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62859052 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.57116593 |
| 20 | CJUN_26792858_Chip-Seq_BT549_Human | 1.54608483 |
| 21 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.52849193 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.49491976 |
| 23 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.48677489 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.48156001 |
| 25 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47475545 |
| 26 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.43137481 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.40115630 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38907650 |
| 29 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.35372405 |
| 30 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.35271163 |
| 31 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31143261 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.30662079 |
| 33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.30309362 |
| 34 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.29715065 |
| 35 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.28771236 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27817309 |
| 37 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.26589515 |
| 38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.26022625 |
| 39 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.24851950 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23304820 |
| 41 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.23283454 |
| 42 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.23104962 |
| 43 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20098735 |
| 44 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19380559 |
| 45 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.17863848 |
| 46 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.17289482 |
| 47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17271756 |
| 48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16689170 |
| 49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16549899 |
| 50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16549899 |
| 51 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.15641394 |
| 52 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.15641394 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15185848 |
| 54 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14943515 |
| 55 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14784924 |
| 56 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14500838 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14264204 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14068028 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11060047 |
| 60 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.10734971 |
| 61 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07127068 |
| 62 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.06706356 |
| 63 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02455358 |
| 64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00161730 |
| 65 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.00130586 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99119755 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99043516 |
| 68 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96858910 |
| 69 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.95606369 |
| 70 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95462563 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94747975 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93828276 |
| 73 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93824900 |
| 74 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.93725433 |
| 75 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92804983 |
| 76 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91134874 |
| 77 | MAF_26560356_Chip-Seq_TH1_Human | 0.90361458 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89873492 |
| 79 | VDR_22108803_ChIP-Seq_LS180_Human | 0.88756805 |
| 80 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.86784255 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86499392 |
| 82 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.85027104 |
| 83 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.84437724 |
| 84 | SPI1_23127762_ChIP-Seq_K562_Human | 0.83796527 |
| 85 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.83390411 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82813582 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.82215615 |
| 88 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.82181168 |
| 89 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82090514 |
| 90 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81763960 |
| 91 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.81138447 |
| 92 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.80848270 |
| 93 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.80189230 |
| 94 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.79369158 |
| 95 | CBP_21632823_ChIP-Seq_H3396_Human | 0.78860433 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78781426 |
| 97 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.77619056 |
| 98 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.76936184 |
| 99 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.76585037 |
| 100 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76397541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 7.62053921 |
| 2 | MP0000749_muscle_degeneration | 6.59495168 |
| 3 | MP0003646_muscle_fatigue | 6.59087887 |
| 4 | MP0000751_myopathy | 5.81628869 |
| 5 | MP0000747_muscle_weakness | 4.27763870 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.13933078 |
| 7 | MP0000759_abnormal_skeletal_muscle | 3.76172015 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.64771937 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.49165639 |
| 10 | MP0005369_muscle_phenotype | 3.43093421 |
| 11 | MP0002269_muscular_atrophy | 3.41424353 |
| 12 | MP0004130_abnormal_muscle_cell | 3.27563171 |
| 13 | MP0000750_abnormal_muscle_regeneration | 3.27291065 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 3.24379300 |
| 15 | MP0005620_abnormal_muscle_contractility | 3.04717669 |
| 16 | MP0002332_abnormal_exercise_endurance | 2.37132632 |
| 17 | MP0000733_abnormal_muscle_development | 2.28652462 |
| 18 | MP0004233_abnormal_muscle_weight | 2.15567701 |
| 19 | MP0005330_cardiomyopathy | 2.10516462 |
| 20 | MP0004185_abnormal_adipocyte_glucose | 2.00587934 |
| 21 | MP0002108_abnormal_muscle_morphology | 1.97249587 |
| 22 | MP0004484_altered_response_of | 1.82247027 |
| 23 | MP0005666_abnormal_adipose_tissue | 1.73563638 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.50013427 |
| 25 | MP0004215_abnormal_myocardial_fiber | 1.49954376 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 1.49459505 |
| 27 | MP0002972_abnormal_cardiac_muscle | 1.43028091 |
| 28 | MP0003828_pulmonary_edema | 1.42851519 |
| 29 | MP0010630_abnormal_cardiac_muscle | 1.42781885 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.37001407 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.36365807 |
| 32 | MP0002971_abnormal_brown_adipose | 1.31132281 |
| 33 | MP0004270_analgesia | 1.25962350 |
| 34 | MP0005375_adipose_tissue_phenotype | 1.17425686 |
| 35 | MP0005670_abnormal_white_adipose | 1.01311692 |
| 36 | MP0001544_abnormal_cardiovascular_syste | 0.95286340 |
| 37 | MP0005385_cardiovascular_system_phenoty | 0.95286340 |
| 38 | MP0001299_abnormal_eye_distance/ | 0.87484209 |
| 39 | MP0004510_myositis | 0.86593053 |
| 40 | MP0005266_abnormal_metabolism | 0.85906453 |
| 41 | MP0000013_abnormal_adipose_tissue | 0.82670128 |
| 42 | MP0004147_increased_porphyrin_level | 0.78633175 |
| 43 | MP0005083_abnormal_biliary_tract | 0.77429533 |
| 44 | MP0003045_fibrosis | 0.76971668 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 0.75050478 |
| 46 | MP0003137_abnormal_impulse_conducting | 0.72599003 |
| 47 | MP0000372_irregular_coat_pigmentation | 0.72280027 |
| 48 | MP0004134_abnormal_chest_morphology | 0.71490312 |
| 49 | MP0003724_increased_susceptibility_to | 0.66990335 |
| 50 | MP0008961_abnormal_basal_metabolism | 0.66871927 |
| 51 | MP0001853_heart_inflammation | 0.61324082 |
| 52 | MP0000343_altered_response_to | 0.59795436 |
| 53 | MP0005076_abnormal_cell_differentiation | 0.59725306 |
| 54 | MP0000266_abnormal_heart_morphology | 0.58535318 |
| 55 | MP0003436_decreased_susceptibility_to | 0.58481283 |
| 56 | MP0004043_abnormal_pH_regulation | 0.57670464 |
| 57 | MP0005334_abnormal_fat_pad | 0.56546997 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 0.54781807 |
| 59 | MP0008775_abnormal_heart_ventricle | 0.52531415 |
| 60 | MP0002127_abnormal_cardiovascular_syste | 0.51533961 |
| 61 | MP0000003_abnormal_adipose_tissue | 0.51353013 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 0.46831333 |
| 63 | MP0000383_abnormal_hair_follicle | 0.45958284 |
| 64 | MP0005166_decreased_susceptibility_to | 0.44666013 |
| 65 | MP0009250_abnormal_appendicular_skeleto | 0.43774277 |
| 66 | MP0000569_abnormal_digit_pigmentation | 0.43088349 |
| 67 | MP0002148_abnormal_hypersensitivity_rea | 0.41239182 |
| 68 | MP0002896_abnormal_bone_mineralization | 0.40064857 |
| 69 | MP0009672_abnormal_birth_weight | 0.40061231 |
| 70 | MP0004782_abnormal_surfactant_physiolog | 0.37235416 |
| 71 | MP0002933_joint_inflammation | 0.36708320 |
| 72 | MP0009115_abnormal_fat_cell | 0.36369972 |
| 73 | MP0001958_emphysema | 0.35141393 |
| 74 | MP0003195_calcinosis | 0.34517440 |
| 75 | MP0005452_abnormal_adipose_tissue | 0.34308124 |
| 76 | MP0003948_abnormal_gas_homeostasis | 0.34121947 |
| 77 | MP0002163_abnormal_gland_morphology | 0.33433340 |
| 78 | MP0004197_abnormal_fetal_growth/weight/ | 0.32258335 |
| 79 | MP0001790_abnormal_immune_system | 0.31918025 |
| 80 | MP0005387_immune_system_phenotype | 0.31918025 |
| 81 | MP0000762_abnormal_tongue_morphology | 0.31903307 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.29931102 |
| 83 | MP0001243_abnormal_dermal_layer | 0.29686957 |
| 84 | MP0002277_abnormal_respiratory_mucosa | 0.28963177 |
| 85 | MP0002234_abnormal_pharynx_morphology | 0.28942728 |
| 86 | MP0003567_abnormal_fetal_cardiomyocyte | 0.28765971 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.27318585 |
| 88 | MP0001879_abnormal_lymphatic_vessel | 0.25103252 |
| 89 | MP0006138_congestive_heart_failure | 0.24903720 |
| 90 | MP0003959_abnormal_lean_body | 0.24821421 |
| 91 | MP0000249_abnormal_blood_vessel | 0.23168066 |
| 92 | MP0005376_homeostasis/metabolism_phenot | 0.22830544 |
| 93 | MP0002128_abnormal_blood_circulation | 0.22716450 |
| 94 | MP0002114_abnormal_axial_skeleton | 0.22612745 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.21996358 |
| 96 | MP0002133_abnormal_respiratory_system | 0.20917108 |
| 97 | MP0005388_respiratory_system_phenotype | 0.20917108 |
| 98 | MP0001943_abnormal_respiration | 0.20084755 |
| 99 | MP0000685_abnormal_immune_system | 0.19645112 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.19567188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 9.00108820 |
| 2 | Exercise-induced myalgia (HP:0003738) | 7.47010304 |
| 3 | Distal arthrogryposis (HP:0005684) | 7.09803026 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.81836924 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.79480863 |
| 6 | Myopathic facies (HP:0002058) | 6.57451957 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 6.15223711 |
| 8 | Round ear (HP:0100830) | 5.54445642 |
| 9 | Ulnar deviation of the wrist (HP:0003049) | 5.43095965 |
| 10 | Difficulty running (HP:0009046) | 4.86272715 |
| 11 | Muscle fiber splitting (HP:0003555) | 4.82009324 |
| 12 | Calcaneovalgus deformity (HP:0001848) | 4.73526237 |
| 13 | EMG: myopathic abnormalities (HP:0003458) | 4.56678654 |
| 14 | Muscle stiffness (HP:0003552) | 4.45958482 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 4.45067262 |
| 16 | Absent phalangeal crease (HP:0006109) | 4.32434338 |
| 17 | Deformed tarsal bones (HP:0008119) | 4.25292322 |
| 18 | Myoglobinuria (HP:0002913) | 4.11552171 |
| 19 | Abnormality of the calf musculature (HP:0001430) | 4.10621095 |
| 20 | Increased connective tissue (HP:0009025) | 3.94539289 |
| 21 | Neck muscle weakness (HP:0000467) | 3.92950927 |
| 22 | Rimmed vacuoles (HP:0003805) | 3.83151694 |
| 23 | Myotonia (HP:0002486) | 3.80359490 |
| 24 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.77255361 |
| 25 | Frequent falls (HP:0002359) | 3.68850123 |
| 26 | Abnormal finger flexion creases (HP:0006143) | 3.61932938 |
| 27 | Rhabdomyolysis (HP:0003201) | 3.60779528 |
| 28 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.48238382 |
| 29 | Subaortic stenosis (HP:0001682) | 3.48238382 |
| 30 | Pelvic girdle muscle weakness (HP:0003749) | 3.38681981 |
| 31 | Shoulder girdle muscle weakness (HP:0003547) | 3.24642505 |
| 32 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.19222621 |
| 33 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.19222621 |
| 34 | Malignant hyperthermia (HP:0002047) | 3.14589318 |
| 35 | Areflexia of lower limbs (HP:0002522) | 3.10572641 |
| 36 | Increased variability in muscle fiber diameter (HP:0003557) | 3.05473289 |
| 37 | Difficulty climbing stairs (HP:0003551) | 2.88526791 |
| 38 | Abnormality of the calcaneus (HP:0008364) | 2.87403744 |
| 39 | Asymmetric septal hypertrophy (HP:0001670) | 2.81754238 |
| 40 | Distal lower limb muscle weakness (HP:0009053) | 2.78994721 |
| 41 | Hyperkalemia (HP:0002153) | 2.77520501 |
| 42 | Progressive muscle weakness (HP:0003323) | 2.69173100 |
| 43 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.68790670 |
| 44 | Hip contracture (HP:0003273) | 2.59249220 |
| 45 | EMG: neuropathic changes (HP:0003445) | 2.57763515 |
| 46 | Proximal amyotrophy (HP:0007126) | 2.56906814 |
| 47 | Slender build (HP:0001533) | 2.54746666 |
| 48 | Facial diplegia (HP:0001349) | 2.53297510 |
| 49 | Sudden death (HP:0001699) | 2.48074967 |
| 50 | Scapular winging (HP:0003691) | 2.46425989 |
| 51 | Distal lower limb amyotrophy (HP:0008944) | 2.45801618 |
| 52 | Spinal rigidity (HP:0003306) | 2.38412556 |
| 53 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.30237547 |
| 54 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.30037790 |
| 55 | Generalized muscle weakness (HP:0003324) | 2.29734842 |
| 56 | Weak cry (HP:0001612) | 2.25762968 |
| 57 | Muscular dystrophy (HP:0003560) | 2.22855136 |
| 58 | Abnormality of the neuromuscular junction (HP:0003398) | 2.19706675 |
| 59 | Fatigable weakness (HP:0003473) | 2.19706675 |
| 60 | Hypoplastic ischia (HP:0003175) | 2.19675306 |
| 61 | Limb-girdle muscle weakness (HP:0003325) | 2.17698031 |
| 62 | Bulbar palsy (HP:0001283) | 2.12032872 |
| 63 | Paralysis (HP:0003470) | 2.11615690 |
| 64 | Ulnar deviation of finger (HP:0009465) | 2.04017034 |
| 65 | Gowers sign (HP:0003391) | 2.03034757 |
| 66 | Muscle fiber inclusion bodies (HP:0100299) | 12.5756414 |
| 67 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 11.4090162 |
| 68 | Nemaline bodies (HP:0003798) | 11.2091140 |
| 69 | Abnormality of the ischium (HP:0003174) | 1.94744373 |
| 70 | Waddling gait (HP:0002515) | 1.91058549 |
| 71 | Lower limb amyotrophy (HP:0007210) | 1.90622536 |
| 72 | Limited hip movement (HP:0008800) | 1.83998045 |
| 73 | Nonprogressive disorder (HP:0003680) | 1.82776617 |
| 74 | Limb-girdle muscle atrophy (HP:0003797) | 1.82218392 |
| 75 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.76953615 |
| 76 | Metatarsus adductus (HP:0001840) | 1.70935904 |
| 77 | Congenital hip dislocation (HP:0001374) | 1.66090547 |
| 78 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.64391193 |
| 79 | Stridor (HP:0010307) | 1.60578378 |
| 80 | Fetal akinesia sequence (HP:0001989) | 1.58379323 |
| 81 | Ventricular tachycardia (HP:0004756) | 1.55037169 |
| 82 | Tarsal synostosis (HP:0008368) | 1.52202377 |
| 83 | Lipoatrophy (HP:0100578) | 1.51889715 |
| 84 | Increased density of long bones (HP:0006392) | 1.48860963 |
| 85 | Dilated cardiomyopathy (HP:0001644) | 1.46926697 |
| 86 | Long clavicles (HP:0000890) | 1.44858035 |
| 87 | Abnormality of the foot musculature (HP:0001436) | 1.44283442 |
| 88 | Achilles tendon contracture (HP:0001771) | 1.42691275 |
| 89 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.40519544 |
| 90 | Increased purine levels (HP:0004368) | 1.40426088 |
| 91 | Hyperuricemia (HP:0002149) | 1.40426088 |
| 92 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.36418926 |
| 93 | Synostosis involving bones of the feet (HP:0009140) | 1.36418926 |
| 94 | Foot dorsiflexor weakness (HP:0009027) | 1.34922709 |
| 95 | Short palpebral fissure (HP:0012745) | 1.30427322 |
| 96 | Gout (HP:0001997) | 1.29232263 |
| 97 | Oligomenorrhea (HP:0000876) | 1.28426542 |
| 98 | Abnormality of potassium homeostasis (HP:0011042) | 1.28421093 |
| 99 | Abnormality of the Achilles tendon (HP:0005109) | 1.26446563 |
| 100 | Adducted thumb (HP:0001181) | 1.25573572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.50230798 |
| 2 | PIK3CG | 4.48123963 |
| 3 | PHKG1 | 3.61237919 |
| 4 | PHKG2 | 3.61237919 |
| 5 | NME1 | 2.81846658 |
| 6 | MAP2K3 | 2.78483418 |
| 7 | MAP3K7 | 2.02556713 |
| 8 | OBSCN | 12.1942784 |
| 9 | DMPK | 1.96443923 |
| 10 | PINK1 | 1.74710260 |
| 11 | NEK1 | 1.49065487 |
| 12 | MAP3K3 | 1.46125660 |
| 13 | MAPK12 | 1.41751471 |
| 14 | ZAK | 1.21819027 |
| 15 | MAP2K4 | 1.18803982 |
| 16 | PIK3CA | 1.18787316 |
| 17 | PDK4 | 1.16348510 |
| 18 | PDK3 | 1.16348510 |
| 19 | MUSK | 1.07529339 |
| 20 | PDK2 | 0.97613053 |
| 21 | TAOK2 | 0.96067312 |
| 22 | NEK9 | 0.79591305 |
| 23 | MAP2K6 | 0.73160249 |
| 24 | ERBB3 | 0.70975971 |
| 25 | STK24 | 0.68268476 |
| 26 | PRKAA2 | 0.62681873 |
| 27 | TAOK1 | 0.62274607 |
| 28 | RIPK1 | 0.62111546 |
| 29 | ACVR1B | 0.60856121 |
| 30 | AKT2 | 0.58784609 |
| 31 | PRKAA1 | 0.57224344 |
| 32 | MAP3K14 | 0.52921351 |
| 33 | MARK3 | 0.50809492 |
| 34 | MAP3K11 | 0.48758286 |
| 35 | FLT3 | 0.48357436 |
| 36 | TXK | 0.47364133 |
| 37 | TRPM7 | 0.44662295 |
| 38 | TYK2 | 0.44108291 |
| 39 | INSRR | 0.43784903 |
| 40 | MAPK11 | 0.42803008 |
| 41 | PKN1 | 0.42773739 |
| 42 | SGK1 | 0.41655406 |
| 43 | PKN2 | 0.39685779 |
| 44 | MAPK7 | 0.38940085 |
| 45 | BCKDK | 0.37924152 |
| 46 | RIPK4 | 0.37526629 |
| 47 | CAMK2G | 0.34612988 |
| 48 | PTK6 | 0.28781346 |
| 49 | MAP3K6 | 0.27797855 |
| 50 | TRIB3 | 0.27452172 |
| 51 | EIF2AK2 | 0.26275323 |
| 52 | CAMK1G | 0.26247490 |
| 53 | CAMK1D | 0.26228421 |
| 54 | PRKG1 | 0.24534621 |
| 55 | SIK1 | 0.23833163 |
| 56 | HCK | 0.22989743 |
| 57 | ROCK1 | 0.22189129 |
| 58 | ZAP70 | 0.20829145 |
| 59 | SGK3 | 0.20715252 |
| 60 | JAK1 | 0.20560960 |
| 61 | JAK3 | 0.20487913 |
| 62 | MAP3K5 | 0.19731120 |
| 63 | LATS1 | 0.19632575 |
| 64 | LIMK1 | 0.18747764 |
| 65 | MAP3K4 | 0.18373444 |
| 66 | JAK2 | 0.17207390 |
| 67 | SGK2 | 0.16780632 |
| 68 | CDK12 | 0.16756287 |
| 69 | MAPK4 | 0.15838661 |
| 70 | EPHB1 | 0.15569487 |
| 71 | RPS6KA3 | 0.15260561 |
| 72 | MAP3K13 | 0.15146382 |
| 73 | CCNB1 | 0.14672059 |
| 74 | TGFBR2 | 0.14238679 |
| 75 | MELK | 0.13158448 |
| 76 | MAPK10 | 0.12767703 |
| 77 | MAPKAPK3 | 0.12517767 |
| 78 | MST1R | 0.12106169 |
| 79 | TBK1 | 0.12076096 |
| 80 | IRAK3 | 0.11913986 |
| 81 | FGFR1 | 0.10596073 |
| 82 | PRKACB | 0.10277228 |
| 83 | YES1 | 0.10057459 |
| 84 | WNK1 | 0.10056084 |
| 85 | CSK | 0.09147093 |
| 86 | CAMK2D | 0.08877320 |
| 87 | IRAK4 | 0.08847219 |
| 88 | STK3 | 0.07997752 |
| 89 | IKBKB | 0.07954775 |
| 90 | GSK3A | 0.07572240 |
| 91 | PDK1 | 0.07564600 |
| 92 | BMPR1B | 0.07319280 |
| 93 | MAPK8 | 0.06735640 |
| 94 | PRKDC | 0.06690208 |
| 95 | PRKACA | 0.06615393 |
| 96 | PRKCQ | 0.05861926 |
| 97 | BRD4 | 0.05463848 |
| 98 | FGFR3 | 0.03686157 |
| 99 | CDK6 | 0.03507129 |
| 100 | CHUK | 0.03153715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.80392093 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.93964244 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.70773799 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.54723199 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.54316041 |
| 6 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.79604156 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 2.49283261 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.23476371 |
| 9 | Insulin resistance_Homo sapiens_hsa04931 | 2.20729528 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.20003000 |
| 11 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.18162486 |
| 12 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.16297631 |
| 13 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.09545181 |
| 14 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.75537871 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.75193111 |
| 16 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.73909282 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.63806916 |
| 18 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.46661719 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.43308504 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.42978426 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42967766 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.37287362 |
| 23 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.28475413 |
| 24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.20145354 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.19189513 |
| 26 | Tight junction_Homo sapiens_hsa04530 | 1.15665031 |
| 27 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.14603733 |
| 28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13753501 |
| 29 | Focal adhesion_Homo sapiens_hsa04510 | 1.12585580 |
| 30 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10833878 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10728574 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07309437 |
| 33 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04638224 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.00295555 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97875091 |
| 36 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.96422832 |
| 37 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96224730 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95680862 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94624163 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94042836 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.94037074 |
| 42 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.92420105 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.90778967 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86470342 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86267929 |
| 46 | Adherens junction_Homo sapiens_hsa04520 | 0.82552029 |
| 47 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.82214220 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.80248948 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79432654 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78977000 |
| 51 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.78125866 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.77906032 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76653970 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76474359 |
| 55 | Malaria_Homo sapiens_hsa05144 | 0.75597484 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 0.74609480 |
| 57 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74570872 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72722220 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.68545036 |
| 60 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67336332 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65777877 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63574223 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 0.62035537 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61513173 |
| 65 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61288200 |
| 66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60989439 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.60130903 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59079252 |
| 69 | Measles_Homo sapiens_hsa05162 | 0.59039178 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.58236815 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57716758 |
| 72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.56802170 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.54797384 |
| 74 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53486083 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52124590 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51411575 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48719272 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44860210 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.40508175 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38325501 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37841784 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.37814105 |
| 83 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34768015 |
| 84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34380495 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33350359 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.33152010 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.32373139 |
| 88 | Insulin secretion_Homo sapiens_hsa04911 | 0.32146873 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31384092 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29909670 |
| 91 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.29134336 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.26349248 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26012270 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.25944212 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.25876385 |
| 96 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.24603769 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.21573686 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.21452350 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20819074 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.20556657 |

